Clinical Trials on 补充缺陷 in United States
总计1024个结果
-
Alnylam Pharmaceuticals完全的
-
C.T. Development America, Inc.完全的淀粉样变性西班牙, 美国, 意大利, 比利时, 荷兰, 印度, 突尼斯, 拉脱维亚, 火鸡, 法国, 德国, 爱沙尼亚, 立陶宛, 波兰, 俄罗斯联邦, 乔治亚州, 英国, 以色列, 埃及, 芬兰, 秘鲁, 瑞典, 乌克兰
-
University College, LondonGlaxoSmithKline; Medical Research Council; University of Oxford完全的
-
Alnylam Pharmaceuticals终止
-
Stanford UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)主动,不招人
-
Pharming Technologies B.V.University of Wisconsin, Madison撤销
-
WestatVersiti; American National Red Cross; The Institute for Transfusion Medicine完全的
-
AbbVie招聘中免疫球蛋白轻链 (AL) 淀粉样变性日本, 美国, 澳大利亚
-
Thomas Jefferson UniversityAuerbach Hematology and Oncology招聘中
-
Cornell UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National Institutes...主动,不招人
-
University of Illinois at ChicagoNational Heart, Lung, and Blood Institute (NHLBI)邀请报名
-
University of PennsylvaniaAstraZeneca; Ionis Pharmaceuticals, Inc.主动,不招人
-
University of CincinnatiThe Christ Hospital撤销
-
Virginia Commonwealth University终止
-
Washington University School of MedicineNational Institutes of Health (NIH); National Institute on Aging (NIA)完全的
-
Rajshekhar Chakraborty, MDGenentech, Inc.招聘中
-
Auerbach Hematology Oncology Associates P CAMAG Pharmaceuticals, Inc.招聘中
-
Dr Jorg TaubelRichmond Pharmacology Limited; National Amyloidosis Centre尚未招聘
-
Austin Neuromuscular CenterAlnylam Pharmaceuticals招聘中多发性神经病 | 转甲状腺素蛋白淀粉样变性 | 野生型甲状腺素运载蛋白相关 (ATTR) 淀粉样变性 | 野生型转甲状腺素蛋白心肌淀粉样变性 | 野生型 ATTR 淀粉样变性美国
-
Jeremy ShefnerBeth Israel Deaconess Medical Center完全的
-
Weill Medical College of Cornell UniversityKaryopharm Therapeutics Inc撤销
-
Stanford UniversityCelgene Corporation完全的